- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有595家主力机构披露2025-12-31报告期持股数据，持仓量总计42.47亿股，占流通A股53.39%
- 波段诊断：
-
技术面诊股
诊断结果：4.0技术面打败了33%的股票
技术面评分前10的股票
近期的平均成本为8.29元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为8.29元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.29","date":1781581278,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2026.06.16","stock":"-2.01","trade":"-0.42","ind":"0.93"},{"date":"2026.06.15","stock":"-0.12","trade":"-0.52","ind":"3.79"},{"date":"2026.06.12","stock":"0.59","trade":"2.48","ind":"0.75"},{"date":"2026.06.11","stock":"1.94","trade":"-1.51","ind":"-0.68"},{"date":"2026.06.10","stock":"0.00","trade":"-0.40","ind":"-2.06"},{"date":"2026.06.09","stock":"-0.72","trade":"1.04","ind":"3.02"},{"date":"2026.06.08","stock":"-2.69","trade":"-3.31","ind":"-3.22"},{"date":"2026.06.05","stock":"0.47","trade":"-0.44","ind":"-2.21"},{"date":"2026.06.04","stock":"-3.41","trade":"-1.37","ind":"-0.27"},{"date":"2026.06.03","stock":"-3.08","trade":"-1.00","ind":"0.73"},{"date":"2026.06.02","stock":"-1.30","trade":"-1.85","ind":"1.63"},{"date":"2026.06.01","stock":"0.88","trade":"-0.06","ind":"-1.51"},{"date":"2026.05.29","stock":"-1.19","trade":"-1.55","ind":"-1.81"},{"date":"2026.05.28","stock":"0.44","trade":"0.01","ind":"0.80"},{"date":"2026.05.27","stock":"1.32","trade":"-1.47","ind":"-0.88"},{"date":"2026.05.26","stock":"-2.89","trade":"-1.68","ind":"0.12"},{"date":"2026.05.25","stock":"1.74","trade":"-0.77","ind":"1.66"},{"date":"2026.05.22","stock":"-1.92","trade":"0.16","ind":"2.30"},{"date":"2026.05.21","stock":"-1.16","trade":"-1.29","ind":"-2.07"},{"date":"2026.05.20","stock":"-4.15","trade":"-0.55","ind":"0.00"},{"date":"2026.05.19","stock":"-3.04","trade":"0.38","ind":"0.26"}]
爱尔眼科,深证成指,医疗服务指数
压力支撑
该股压力位为8.32元，支撑位为8.22元。
[{"text":"\u538b\u529b\u4f4d","value":"8.32","date":1781539200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.22","date":1781539200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了7%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月17日 12:30
| 机构今日流向(万元) | -1030.00 | 机构5日流向(万元) | -2311.31 |
| 机构10日流向(万元) | -6343.86 | 机构20日流向(万元) | -19126.21 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少27250.6万股，其中基金净减仓281家，主力净减仓120家，请投资者中长期谨慎为宜。
截止2025-12-31，共595家主力机构（基金593家，一般法人2家），持仓量总计424734.2万股，占流通A股53.39%
其中，基金持仓与2025-06-30相比：
增仓：66家 ，增持 2403.11万股
减仓：347家 ，减持 19737.79万股
新出现在主力名单中：142家 ，持有8673.65万股
从主力名单中消失：262家 ，原持有14506.4万股
其中，基金持仓与2025-06-30相比：
增仓：66家 ，增持 2403.11万股
减仓：347家 ，减持 19737.79万股
新出现在主力名单中：142家 ，持有8673.65万股
从主力名单中消失：262家 ，原持有14506.4万股
消息面诊股
诊断结果：5.6消息面打败了24%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 爱尔眼科：6月16日获融资买入5436.84万元
2026-06-17 - 爱尔眼科与蔡司医疗深化合作 拓展眼健康生态新格局
2026-06-16 - 各大行业龙头股当前股价，预期目标价格！
2026-06-16 - 爱尔眼科：6月15日获融资买入6341.06万元
2026-06-16 - 补税风暴下，“眼茅”爱尔眼科走到十字路口
2026-06-16 - 券商观点|医药生物行业周报：边际修复改善，看好眼科
2026-06-16 - 【朝闻国盛0616】AIDC智能母线监测：800V
2026-06-16 - 创新药迎增持回购潮！上百医药企业投下“信心票”
2026-06-15 - 股市调整不慌！这10只医药龙头被严重低估值得关注，
2026-06-15 - 青岛爱尔眼科多位医师荣获全国首批龙晶 PR规划师认
2026-06-15
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2026-06-10 |
| 一般消息 | 募资投向 | 2026-06-05 | |
| 一般消息 | 高管变动 | 为积极配合公司相关工作 | 2026-05-18 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-24 |
| 利好 | 分红转增 | 10派1元(含税) | 2026-04-24 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-24 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-22 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-27 |
| 利好 | 分红转增 | 10派0.8元(含税) | 2025-11-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-17 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-04 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.0行业面打败了73%的股票
医疗服务行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2026.06.16","price":"0.93","value":"-0.42"},{"date":"2026.06.15","price":"3.79","value":"-0.52"},{"date":"2026.06.12","price":"0.75","value":"2.48"},{"date":"2026.06.11","price":"-0.68","value":"-1.51"},{"date":"2026.06.10","price":"-2.06","value":"-0.40"},{"date":"2026.06.09","price":"3.02","value":"1.04"},{"date":"2026.06.08","price":"-3.22","value":"-3.31"},{"date":"2026.06.05","price":"-2.21","value":"-0.44"},{"date":"2026.06.04","price":"-0.27","value":"-1.37"},{"date":"2026.06.03","price":"0.73","value":"-1.00"},{"date":"2026.06.02","price":"1.63","value":"-1.85"},{"date":"2026.06.01","price":"-1.51","value":"-0.06"},{"date":"2026.05.29","price":"-1.81","value":"-1.55"},{"date":"2026.05.28","price":"0.80","value":"0.01"},{"date":"2026.05.27","price":"-0.88","value":"-1.47"},{"date":"2026.05.26","price":"0.12","value":"-1.68"},{"date":"2026.05.25","price":"1.66","value":"-0.77"},{"date":"2026.05.22","price":"2.30","value":"0.16"},{"date":"2026.05.21","price":"-2.07","value":"-1.29"},{"date":"2026.05.20","price":"0.00","value":"-0.55"},{"date":"2026.05.19","price":"0.26","value":"0.38"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 皓元医药 | 5.85% | 6.70% | 5.9分 |
| 2 | ST中珠 | -1.18% | -4.56% | 4.5分 |
| 3 | 药明康德 | -2.05% | 5.01% | 5.0分 |
| 4 | 华厦眼科 | -2.23% | 3.12% | 4.9分 |
| 5 | 迪安诊断 | -2.85% | 10.62% | 5.6分 |
| 6 | 博腾股份 | -3.34% | 5.04% | 5.3分 |
| 8 | 凯莱英 | -4.94% | 0.62% | 4.5分 |
| 10 | 百花医药 | -7.07% | -2.00% | 4.7分 |
| 12 | 成都先导 | -8.40% | -1.17% | 5.6分 |
| 14 | 通策医疗 | -9.21% | 3.38% | 5.3分 |
| 16 | 大东方 | -10.16% | -4.96% | 4.3分 |
| 18 | 南华生物 | -11.54% | -0.61% | 5.3分 |
| 20 | 华康洁净 | -12.01% | -3.94% | 6.0分 |
| 22 | 百诚医药 | -13.43% | -4.71% | 5.3分 |
| 24 | 泰格医药 | -13.70% | 6.35% | 5.7分 |
| 26 | 泓博医药 | -14.37% | 2.87% | 4.5分 |
| 28 | 大湖股份 | -14.80% | -3.70% | 5.0分 |
| 30 | 药康生物 | -14.86% | -1.86% | 5.1分 |
| 32 | 华大基因 | -15.70% | -0.38% | 3.9分 |
| 34 | 新里程 | -16.16% | -9.43% | 4.1分 |
| 36 | 和元生物 | -16.28% | -1.10% | 4.1分 |
| 38 | 益诺思 | -16.95% | -0.83% | 4.8分 |
| 40 | 美迪西 | -17.63% | 1.25% | 4.6分 |
| 42 | 皓宸医疗 | -17.86% | -4.56% | 4.4分 |
| 44 | 诺禾致源 | -18.41% | -4.57% | 5.8分 |
| 46 | 盈康生命 | -18.95% | -3.33% | 4.6分 |
| 48 | 兰卫医学 | -20.13% | -1.83% | 4.5分 |
| 50 | 普瑞眼科 | -20.71% | 3.52% | 5.2分 |
| 52 | 博济医药 | -21.19% | -0.59% | 4.5分 |
| 54 | 三博脑科 | -24.78% | -0.02% | 4.4分 |
| 56 | 创新医疗 | -30.80% | 0.06% | 4.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/102 ， 13/102。
[{"date":"2026-03-31","value":"5.24","vol":"0.96"},{"date":"2025-12-31","value":"15.18","vol":"2.21"},{"date":"2025-09-30","value":"14.44","vol":"3.24"},{"date":"2025-06-30","value":"9.68","vol":"2.24"},{"date":"2025-03-31","value":"4.93","vol":"0.88"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.24 | 15.18 | 14.44 | 9.68 | 4.93 |
| 行业(%) | 0.96 | 2.21 | 3.24 | 2.24 | 0.88 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"47.73","vol":"34.16"},{"date":"2025-12-31","value":"47.11","vol":"34.36"},{"date":"2025-09-30","value":"49.27","vol":"36.06"},{"date":"2025-06-30","value":"48.56","vol":"36.21"},{"date":"2025-03-31","value":"48.02","vol":"35.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
47.73 | 47.11 | 49.27 | 48.56 | 48.02 |
| 行业(%) | 34.16 | 34.36 | 36.06 | 36.21 | 35.05 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 28/102 ， 29/102。
[{"date":"2026-03-31","value":"6.15","vol":"16.75"},{"date":"2025-12-31","value":"6.53","vol":"8.22"},{"date":"2025-09-30","value":"7.25","vol":"3.06"},{"date":"2025-06-30","value":"9.12","vol":"2.87"},{"date":"2025-03-31","value":"15.97","vol":"-0.73"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
6.15 | 6.53 | 7.25 | 9.12 | 15.97 |
| 行业(%) | 16.75 | 8.22 | 3.06 | 2.87 | -0.73 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"12.46","vol":"79.49"},{"date":"2025-12-31","value":"-8.88","vol":"23.26"},{"date":"2025-09-30","value":"-9.76","vol":"20.05"},{"date":"2025-06-30","value":"0.05","vol":"-63.31"},{"date":"2025-03-31","value":"16.71","vol":"-22.07"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
12.46 | -8.88 | -9.76 | 0.05 | 16.71 |
| 行业(%) | 79.49 | 23.26 | 20.05 | -63.31 | -22.07 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 3/102 ， 14/102。
[{"date":"2026-03-31","value":"0.17","vol":"0.10"},{"date":"2025-12-31","value":"0.64","vol":"0.44"},{"date":"2025-09-30","value":"0.51","vol":"0.32"},{"date":"2025-06-30","value":"0.34","vol":"0.21"},{"date":"2025-03-31","value":"0.18","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.64 | 0.51 | 0.34 | 0.18 |
| 行业(次) | 0.10 | 0.44 | 0.32 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"3.29","vol":"3.44"},{"date":"2025-12-31","value":"12.02","vol":"15.84"},{"date":"2025-09-30","value":"8.41","vol":"10.95"},{"date":"2025-06-30","value":"5.73","vol":"7.15"},{"date":"2025-03-31","value":"3.33","vol":"3.62"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.29 | 12.02 | 8.41 | 5.73 | 3.33 |
| 行业(次) | 3.44 | 15.84 | 10.95 | 7.15 | 3.62 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"26.71","vol":"0.86"},{"date":"2025-12-31","value":"18.37","vol":"20.95"},{"date":"2025-09-30","value":"28.05","vol":"16.52"},{"date":"2025-06-30","value":"28.85","vol":"16.38"},{"date":"2025-03-31","value":"30.21","vol":"-0.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 26.71 | 18.37 | 28.05 | 28.85 | 30.21 |
| 行业 | 0.86 | 20.95 | 16.52 | 16.38 | -0.79 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.94","vol":"0.89"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.78","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.94 | - | 0.78 | - |
| 行业 | 0.00 | 0.89 | 0.01 | 0.91 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/102 ， 7/102。
[{"date":"2026-03-31","value":"1.44","vol":"3.37"},{"date":"2025-12-31","value":"1.24","vol":"3.64"},{"date":"2025-09-30","value":"1.51","vol":"3.67"},{"date":"2025-06-30","value":"1.39","vol":"3.57"},{"date":"2025-03-31","value":"1.62","vol":"3.68"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.44 | 1.24 | 1.51 | 1.39 | 1.62 |
| 行业 | 3.37 | 3.64 | 3.67 | 3.57 | 3.68 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.25","vol":"2.78"},{"date":"2025-12-31","value":"1.07","vol":"3.00"},{"date":"2025-09-30","value":"1.30","vol":"2.94"},{"date":"2025-06-30","value":"1.20","vol":"2.87"},{"date":"2025-03-31","value":"1.44","vol":"2.97"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.25 | 1.07 | 1.30 | 1.20 | 1.44 |
| 行业 | 2.78 | 3.00 | 2.94 | 2.87 | 2.97 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 18/102 ， 24/102。
[{"date":"2026-03-31","value":"32.72","vol":"32.97"},{"date":"2025-12-31","value":"36.20","vol":"32.98"},{"date":"2025-09-30","value":"33.53","vol":"32.60"},{"date":"2025-06-30","value":"34.69","vol":"33.58"},{"date":"2025-03-31","value":"33.30","vol":"32.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
32.72 | 36.20 | 33.53 | 34.69 | 33.30 |
| 行业(%) | 32.97 | 32.98 | 32.60 | 33.58 | 32.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.52","vol":"0.97"},{"date":"2025-12-31","value":"0.60","vol":"0.97"},{"date":"2025-09-30","value":"0.54","vol":"0.92"},{"date":"2025-06-30","value":"0.56","vol":"0.96"},{"date":"2025-03-31","value":"0.53","vol":"0.96"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.52 | 0.60 | 0.54 | 0.56 | 0.53 |
| 行业(%) | 0.97 | 0.97 | 0.92 | 0.96 | 0.96 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国信证券 | 2026-06-03 | 买入 | 买入 |
| 招商证券 | 2026-05-22 | 增持 | |
| 中信建投证券 | 2026-05-17 | 买入 | |
| 西部证券 | 2026-05-14 | 增持 | |
| 中信证券 | 2026-05-11 | 买入 | |
| 华安证券 | 2026-05-08 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"25.24","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"33.59","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"35.56","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"32.40","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"37.88","blueLineValue":"0.41","type":"YC"}]